K. Bettinson

Assessment of disease progression in dysferlinopathy

U. Moore, Marni Jacobs, M. James, Anna Mayhew et autres

OBJECTIVE: To assess the ability of functional measures to detect disease progression in dysferlinopathy over 6 months and 1 year. METHODS: One hundred ninety-three patients with dysferlinopathy were recruited to the Jain Foundation's International Clinical Outcome Study for Dysferlinopathy. Baseline, 6-month, and …

gb (code pays fourni par la source)

Data from: Assessment of disease progression in dysferlinopathy – a one year cohort study

Volker Straub, U. Moore, Marni Jacobs, M. James et autres

Objective: To assess the ability of functional measures to detect disease progression in dysferlinopathy over 6 months and 1 year. Methods: 193 patients with dysferlinopathy were recruited to the Jain Foundation’s International Clinical Outcome Study for Dysferlinopathy. Baseline, 6 months and 1 …

gb, us (code pays fourni par la source)

Is cardiac dysfunction a feature of dysferlinopathy? Data from the clinical outcome study of dysferlinopathy

Roberto Fernández‐Torrón, Elizabeth Harris, John Bourke, K. Bettinson et autres

gb, de, us, au, fr, es, jp, it (code pays fourni par la source)

Clinical outcome study for dysferlinopathy: Sensitivity of outcome measures over one-year

U. Moore, M. James, A. Mayhew, Marni Jacobs et autres

Development of a robust disease specific functional measure suitable for trials in ambulant and non-ambulant individuals with dysferlinopathy

M. James, A. Mayhew, Michelle Eagle, U. Moore et autres

Clinical outcome study for dysferlinopathy: One-year follow-up

Carmen Paradas, U. Moore, M. James, A. Mayhew et autres

es, gb, fr, us (code pays fourni par la source)

Development of a robust disease specific functional measure suitable for trials in ambulant and non-ambulant individuals with dysferlinopathy

M. James, A. Mayhew, Michelle Eagle, U. Moore et autres

gb (code pays fourni par la source)

The Clinical Outcome Study for dysferlinopathy

Elizabeth Harris, Catherine L. Bladen, Anna Mayhew, M. James et autres

OBJECTIVE: To describe the baseline clinical and functional characteristics of an international cohort of 193 patients with dysferlinopathy. METHODS: The Clinical Outcome Study for dysferlinopathy (COS) is an international multicenter study of this disease, evaluating patients with genetically confirmed dysferlinopathy over 3 …

au, us, it, es, jp, gb, de (code pays fourni par la source)

Preparation of a disease specific functional measure suitable for trials in dysferlinopathy

A. Mayhew, M. James, M. Eagle, Chris Bladen et autres

us (code pays fourni par la source)

BIRMINGHAM HIP RESURFACING (BHR) VERSUS TOTAL HIP REPLACEMENT (THR): A STUDY COMPARING PATIENT REPORTED OUTCOMES AT FIVE YEARS

Rahul Kakkar, Jayasree Ramaskandhan, K. Bettinson, Karthikeyan Muthumayandi et autres

Birmingham Metal-on-metal total hip resurfacing (BHR) is a bone-conserving option for patients with advanced articular damage. While the outcomes of Total Hip Replacement (THR) are well documented, there is a paucity of literature comparing the patient reported outcomes of BHR versus THR. …

gb (code pays fourni par la source)

G.P.247

Elizabeth Harris, K. Bettinson, M. James, Anna Mayhew et autres

gb (code pays fourni par la source)

Two-Year Outcomes of MOBILITY Total Ankle Replacement

Jayasree Ramaskandhan, R. Kakwani, Simon Kometa, K. Bettinson et autres

BACKGROUND: There is little literature on patient-reported outcomes following total ankle replacement in patients with osteoarthritis, posttraumatic osteoarthritis, and rheumatoid arthritis. We compared the differences in demographic data and clinical and patient-reported outcomes among patients with those types of arthritis who underwent …

gb (code pays fourni par la source)